TY  - JOUR
AU  - Esteban-Fernandez, Alberto
AU  - Ortiz Cortes, Carolina
AU  - Lopez-Fernandez, Silvia
AU  - Recio Mayoral, Alejandro
AU  - Camacho Jurado, Francisco Javier
AU  - Gomez Otero, Ines
AU  - Molina, Maria
AU  - Almenar Bonet, Luis
AU  - Lopez-Vilella, Raquel
PY  - 2022
DO  - 10.1002/ehf2.13976
UR  - http://hdl.handle.net/10668/21917
T2  - ESC heart failure
AB  - Hyperkalaemia (HK) is common in heart failure (HF) patients, related to renal dysfunction and medical treatment. It limits medical therapy optimization, which impacts prognosis. New potassium (K) binders help control HK, allowing better medical...
LA  - en
PB  - John Wiley & Sons Ltd.
KW  - Heart failure
KW  - Hyperkalaemia
KW  - Patiromer
KW  - Potassium binders
KW  - Aged
KW  - Female
KW  - Humans
KW  - Male
KW  - Heart Failure
KW  - Hyperkalemia
KW  - Mineralocorticoid Receptor Antagonists
KW  - Polymers
KW  - Potassium
KW  - Middle Aged
KW  - Aged, 80 and over
TI  - Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life.
TY  - research article
VL  - 9
ER  -